EarningsQ3 2024 Earnings Report

Denali Therapeutics (4DN) Q3 2024 Earnings Report

7 Followers

DE:4DN Q3 2024 EPS Results

Actual EPS-€0.56

Consensus EPS-€0.53

Beat/MissMissed by -€0.03

One Year Ago EPS-€0.64

Actual Revenue€0.00

Expected Revenue€5.62M

Beat/MissMissed by -€5.62M

YoY Revenue Growth-100.00%

QuarterQ3 2024

Date11/06/2024

TimeAfter Close

Conference CallWednesday, November 6, 2024

DE:4DN Upcoming Earnings

Denali Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-0.33 / -	-0.66	―
Aug 06, 2026	2026 (Q2)	-0.46 / -0.61	-0.643	5.56% (+0.04)
May 07, 2026	2026 (Q1)	-0.65 / -0.62	-0.696	11.54% (+0.08)
Feb 26, 2026	2025 (Q4)	-0.66 / -0.65	-0.598	-8.96% (-0.05)
Nov 06, 2025	2025 (Q3)	-0.67 / -0.66	-0.562	-17.46% (-0.10)
Aug 11, 2025	2025 (Q2)	-0.63 / -0.64	-0.527	-22.03% (-0.12)
May 06, 2025	2025 (Q1)	-0.62 / -0.70	-0.607	-14.71% (-0.09)
Feb 27, 2025	2024 (Q4)	-0.71 / -0.60	-0.768	22.09% (+0.17)
Nov 06, 2024	2024 (Q3)	-0.53 / -0.56	-0.643	12.50% (+0.08)
Aug 01, 2024	2024 (Q2)	-0.63 / -0.53	1.16	-145.38% (-1.69)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed